Skip to main content
Clinical Trials/NCT02137473
NCT02137473
Completed
Not Applicable

Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 2-Bovine vs. Human Milk-Based Fortifier Study

The Hospital for Sick Children18 sites in 1 country127 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Very Low Birth Weight Infant (<1250g)
Sponsor
The Hospital for Sick Children
Enrollment
127
Locations
18
Primary Endpoint
Feeding tolerance
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Most very low birth weight infants accumulate a nutrient deficit in hospital due to minimal nutrient reserves and elevated nutritional requirements which may contribute to poor outcome. Adding nutrients to human milk improves their nutritional status and growth, but it is unclear if adding bovine protein-based fortifiers as is the current standard of care has some unintended negative consequences to neonates. Infants will be randomized to have their feeds (mother's own milk or pasteurized donor breastmilk) nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier and will be followed in hospital to assess feeding tolerance, growth, gut inflammation, mother's milk and infant gut microbiome, and neonatal morbidity and mortality.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
March 2016
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Deborah O'Connor

Senior Associate Scientist, Research Institute

The Hospital for Sick Children

Eligibility Criteria

Inclusion Criteria

  • \<1250g birth weight
  • Parent(s) or guardian(s) agree to use donor breastmilk if own mother's milk supply is insufficient

Exclusion Criteria

  • Infant receives formula or a nutrient fortifier prior to randomization
  • \>day 14 at the time of enrollment and enteral feeds have not commenced
  • Infants with major congenital or chromosomal anomalies that could impact growth
  • Enrollment in another research study affecting nutritional management during the feeding intervention
  • Reasonable potential that the infant will be transferred to a neonatal intensive care unit where the study protocol will not be continued

Outcomes

Primary Outcomes

Feeding tolerance

Time Frame: 84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first

Percentage of infants with a significant feeding interruption as defined by days feedings held for ≥12 hours OR feeds reduced by \>50% (ml/kg/d) not due to a clinical procedure or transitioning to the breast

Secondary Outcomes

  • Growth(84 days of age, hospital discharge or when able to consume two oral feeds a day without supplementation (e.g. tube feeding), whichever comes first)

Study Sites (18)

Loading locations...

Similar Trials